Article info
PDFGenetics and genomics
Research
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer
- Correspondence to Dr Manish Kohli; kohli.manish{at}mayo.edu
Citation
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer
Publication history
- Received October 21, 2015
- Revised December 23, 2015
- Accepted February 9, 2016
- First published April 15, 2016.
Online issue publication
April 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/